Difluprednate Ophthalmic Emulsion
Product Images NDC 43598-588

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Difluprednate Ophthalmic Emulsion (NDC 43598-588). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label (Bottle Label)

Label for Difluprednate Ophthalmic Emulsion 0.05%, sterile ophthalmic emulsion in a 5 mL container. The label indicates storage instructions (15°C to 25°C), advises not to freeze, and to protect from light. Distributed by Dr. Reddy's Laboratories Inc., Princeton, NJ, made in India. Includes barcode and space for lot number and expiration date.*

FDA Label Image

Carton Label (Carton Label)

Carton label for Difluprednate Ophthalmic Emulsion 0.05%, a sterile 5 mL topical ophthalmic emulsion. The label indicates Rx only, manufactured by Dr. Reddy's Laboratories Inc., with NDC 43598-588-11. Active ingredient concentration and storage instructions are provided, alongside ingredient and preservative details. The label includes barcodes and distributor information.*

FDA Label Image

Figure 1 (Figure1)

A bar chart titled 'Percent of Subjects with Anterior Chamber Cells Clearing (Cell Count = 0)' comparing Difluprednate ophthalmic emulsion 0.05% QID and placebo at Day 8 and Day 15. The chart shows higher clearance percentages for Difluprednate (22% at Day 8, 41% at Day 15) compared to placebo (8% at Day 8, 12% at Day 15), with statistical significance indicated (P<0.05).*

FDA Label Image

Figure 2 (Figure2)

A bar chart titled 'Percent of Subjects who were Pain Free' comparing Difluprednate ophthalmic emulsion 0.05% QID (n=107) and placebo (n=220) over Days 3, 8, and 15. The chart shows higher percentages of pain-free subjects with Difluprednate (45%, 58%, 63%) versus placebo (25%, 27%, 35%), with statistically significant differences indicated by asterisks at each time point.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure (Structure)

Chemical structure of Difluprednate, the active ingredient in Difluprednate Ophthalmic Emulsion .5 mg/mL by Dr. Reddy's Laboratories Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.